Crossmark

Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study

Crossref DOI link: https://doi.org/10.1136/openhrt-2023-002555

Published Online: 2024-03-01

Published Print: 2024-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Fritz Hansson, Astrid

Modica, Angelo

Renlund, Henrik

Christersson, Christina

Held, Claes

Batra, Gorav https://orcid.org/0000-0002-2480-9547
Funding

Funding for this research was provided by:

Bristol Myers Squibb

Pfizer
License Information

License valid from 2024-03-01